What does HistoIndex do?
HistoIndex is a Singapore-based healthcare company that develops imaging solutions for biological tissues by combining biophotonic technology with AI-based analysis. Its digital pathology tools help visualize and quantify fibrosis, accelerating clinical research and pharmaceutical drug development.
How much did they raise?
The company raised SGD9M in a funding round led by OCBC, with participation from ZIG Ventures and SEEDS Capital.
What are their plans for the money?
HistoIndex plans to use the funds to expand its operations and further enhance its R&D efforts, potentially advancing the accuracy and efficiency of fibrosis detection and drug efficacy assessments.
What have they achieved so far?
The company has already launched its first laboratory developed test, FibroSIGHT, in the US, which empowers clinicians with advanced liver fibrosis assessment.
